<link rel="stylesheet" href="http://raw.githubusercontent.com/sindresorhus/github-markdown-css/gh-pages/github-markdown.css">
<style>
    .markdown-body {
        min-width: 200px;
        max-width: 790px;
        margin: 0 auto;
        padding: 30px;
    }
</style>
<article class="markdown-body">

<h1>Horseradish and its effects on breast cancer</h1>

Summary generated using:
<code>$shovel3 query.concatConclusions &#x27;breast cancer horseradish site:ncbi.nlm.nih.gov&#x27; 40 includeReference=True</code>

<ul>

      <li>
        It should be possible to use LSC for the routine measurement of nuclear markers in FNAs from human breast carcinomas. Copyright 2000 Wiley-Liss, Inc.
        <ul>
          <li>Journal: </li>
          <li>Date: </li>
          <li><a href="http://www.ncbi.nlm.nih.gov/pubmed/11042612">Link to article</a></li>
        </ul
      </li>

      <li>
        The method of measuring Ki-67 expression by DAB staining combined with optical enhancement filters and quantification via computer-assisted image analysis techniques produced objective and reproducible results. As such, this method can offer (1) less intraobserver and interobserver variability, (2) a digital archival record, and (3) a baseline for digital exchange of information between studies.
        <ul>
          <li>Journal: </li>
          <li>Date: </li>
          <li><a href="http://www.ncbi.nlm.nih.gov/pubmed/11444192">Link to article</a></li>
        </ul
      </li>

      <li>
        We have developed a protocol that allows simultaneous visualization of the HER2 IHC and HER2 &amp; CEN17 BISH targets. This automated protocol facilitated the determination of HER2 protein and HER2 gene status in randomly selected breast cancer samples, particularly in cases that were equivocal or exhibited tumor heterogeneity. The HER2 gene-protein assay produced results virtually equivalent to those of the single FDA-approved HER2 IHC and HER2 &amp; CEN17 BISH assays.
        <ul>
          <li>Journal: </li>
          <li>Date: </li>
          <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22647525/">Link to article</a></li>
        </ul
      </li>

      <li>
        Low ATM protein expression in both malignant tumor and stromal compartments likely contributes to the aggressive nature of breast cancer and is an independent prognostic factor associated with worse survival in HNBC patients.
        <ul>
          <li>Journal: </li>
          <li>Date: </li>
          <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453198/">Link to article</a></li>
        </ul
      </li>

      <li>
        Rapid mER-Î±-mediated nongenomic signaling cascades generate cAMP and downstream signaling events, which contribute to the regulation of breast cancer cell number.
        <ul>
          <li>Journal: </li>
          <li>Date: </li>
          <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064104/">Link to article</a></li>
        </ul
      </li>

</ul>

</article>
